Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Other Non-Current Assets: 2011-2025

Historic Other Non-Current Assets for Abeona Therapeutics (ABEO) over the last 15 years, with Sep 2025 value amounting to $541,000.

  • Abeona Therapeutics' Other Non-Current Assets rose 60.06% to $541,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $541,000, marking a year-over-year increase of 60.06%. This contributed to the annual value of $338,000 for FY2024, which is negligibly% changed negligibly from last year.
  • Per Abeona Therapeutics' latest filing, its Other Non-Current Assets stood at $541,000 for Q3 2025, which was up 60.06% from $338,000 recorded in Q2 2025.
  • In the past 5 years, Abeona Therapeutics' Other Non-Current Assets registered a high of $5.9 million during Q4 2021, and its lowest value of $338,000 during Q4 2022.
  • Moreover, its 3-year median value for Other Non-Current Assets was $338,000 (2025), whereas its average is $356,455.
  • Within the past 5 years, the most significant YoY rise in Abeona Therapeutics' Other Non-Current Assets was 504.21% (2022), while the steepest drop was 94.26% (2022).
  • Over the past 5 years, Abeona Therapeutics' Other Non-Current Assets (Quarterly) stood at $5.9 million in 2021, then slumped by 94.26% to $338,000 in 2022, then remained steady at $338,000 in 2023, then remained steady at $338,000 in 2024, then surged by 60.06% to $541,000 in 2025.
  • Its Other Non-Current Assets stands at $541,000 for Q3 2025, versus $338,000 for Q2 2025 and $338,000 for Q1 2025.